knowledge -WSS

knowledge

author：Wikipedia 2025-08-26 23:45:55 - browse：2874

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Pharma budget tightening trickles down to Doximity

WSS

Readout Newsletter: Amgen, Regeneron, BGI Group and more

The history of OxyContin, told through Purdue Pharma documents

Target recalls 2.2 million additional candles due to laceration, burn hazards

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Adopting new red light myopia treatments may be short

Why Novartis is going to walk from its acquisition of MorphoSys

explore

knowledge

hotspot

Sports medicine is finally prioritizing gender equality

The Biogen Aduhelm mess could happen again

Jerome Adams on the need for new antivirals for Covid

Timeline: Special counsel's investigation into Trump's handling of classified documents

Dobbs anniversary: the lost opportunity of abortion as health care

A protest over insulin prices is seen as a fight for life

Sports medicine is finally prioritizing gender equality

Newly revealed memo details efforts to keep Trump in power following election loss

At least 13 dead in Texas as scorching temps continue

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

focus

Unique patient identifier: Experts argue the benefits, pitfalls

Gene therapy for Afghan refugees’ infant will be fully covered

Devoted Health’s losses in Medicare Advantage persist

GOP presidential candidates start declaring their loyalty

Newly revealed memo details efforts to keep Trump in power following election loss

Readout LOUD: Venture capital, Gilead, and more M&A

focus

hotspot

leisure time

leisure time